nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Caffeine—PRKDC—salivary gland cancer	0.113	0.505	CrCbGaD
Pentoxifylline—PDE5A—Nitric oxide stimulates guanylate cyclase—GUCY1A3—salivary gland cancer	0.0911	0.138	CbGpPWpGaD
Pentoxifylline—Caffeine—ATM—salivary gland cancer	0.0647	0.29	CrCbGaD
Pentoxifylline—Caffeine—PIK3CA—salivary gland cancer	0.0458	0.205	CrCbGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—SLC25A3—salivary gland cancer	0.0457	0.0693	CbGpPWpGaD
Pentoxifylline—PDE5A—Platelet homeostasis—GUCY1A3—salivary gland cancer	0.0355	0.0538	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.019	0.0288	CbGpPWpGaD
Pentoxifylline—NT5E—Differentiation Pathway—NOTCH1—salivary gland cancer	0.0167	0.0253	CbGpPWpGaD
Pentoxifylline—NT5E—connective tissue—salivary gland cancer	0.0149	0.126	CbGeAlD
Pentoxifylline—NT5E—epithelium—salivary gland cancer	0.0141	0.12	CbGeAlD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0133	0.0202	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—MYB—salivary gland cancer	0.0133	0.0201	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IGFBP2—salivary gland cancer	0.0129	0.0195	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—JMJD1C—salivary gland cancer	0.0123	0.0187	CbGpPWpGaD
Pentoxifylline—PDE4A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0121	0.0183	CbGpPWpGaD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.0117	0.0178	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—GUCY1A3—salivary gland cancer	0.0115	0.0174	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0112	0.017	CbGpPWpGaD
Pentoxifylline—NT5E—lymphoid tissue—salivary gland cancer	0.0109	0.0924	CbGeAlD
Pentoxifylline—ADORA1—saliva-secreting gland—salivary gland cancer	0.00995	0.0846	CbGeAlD
Pentoxifylline—PDE5A—connective tissue—salivary gland cancer	0.00964	0.082	CbGeAlD
Pentoxifylline—ADORA1—Circadian rythm related genes—CRTC1—salivary gland cancer	0.00944	0.0143	CbGpPWpGaD
Pentoxifylline—PDE5A—epithelium—salivary gland cancer	0.00915	0.0778	CbGeAlD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.00874	0.0133	CbGpPWpGaD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.00799	0.0121	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—GUCY1A3—salivary gland cancer	0.00795	0.0121	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—GAS6—salivary gland cancer	0.00795	0.0121	CbGpPWpGaD
Pentoxifylline—ADORA2A—lymphoid tissue—salivary gland cancer	0.00774	0.0658	CbGeAlD
Pentoxifylline—ADORA1—Circadian rythm related genes—MC3R—salivary gland cancer	0.0077	0.0117	CbGpPWpGaD
Pentoxifylline—PDE4B—parotid gland—salivary gland cancer	0.00768	0.0653	CbGeAlD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00741	0.0112	CbGpPWpGaD
Pentoxifylline—PDE4B—saliva-secreting gland—salivary gland cancer	0.00736	0.0626	CbGeAlD
Pentoxifylline—ADORA2A—Circadian rythm related genes—CRTC1—salivary gland cancer	0.00729	0.0111	CbGpPWpGaD
Pentoxifylline—ADORA2A—HIF-2-alpha transcription factor network—CREBBP—salivary gland cancer	0.00662	0.01	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00635	0.00963	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0063	0.00956	CbGpPWpGaD
Pentoxifylline—NT5E—lymph node—salivary gland cancer	0.00613	0.0521	CbGeAlD
Pentoxifylline—ADORA2A—Circadian rythm related genes—MC3R—salivary gland cancer	0.00594	0.00901	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—PRKDC—salivary gland cancer	0.00583	0.00885	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ISYNA1—salivary gland cancer	0.00561	0.00851	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0054	0.00819	CbGpPWpGaD
Pentoxifylline—PDE4B—lymphoid tissue—salivary gland cancer	0.00494	0.042	CbGeAlD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.00489	0.00742	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00487	0.00738	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—MC3R—salivary gland cancer	0.00484	0.00734	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—MYB—salivary gland cancer	0.00473	0.00717	CbGpPWpGaD
Pentoxifylline—PDE4A—lymph node—salivary gland cancer	0.00468	0.0398	CbGeAlD
Pentoxifylline—NT5E—Metabolism—MARCKS—salivary gland cancer	0.00457	0.00694	CbGpPWpGaD
Pentoxifylline—ADORA2A—HIF-2-alpha transcription factor network—EP300—salivary gland cancer	0.00451	0.00684	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—PRKDC—salivary gland cancer	0.0045	0.00683	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00442	0.0067	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PYGB—salivary gland cancer	0.00425	0.00645	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF16—salivary gland cancer	0.00421	0.00639	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00417	0.00632	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—MC3R—salivary gland cancer	0.00411	0.00624	CbGpPWpGaD
Pentoxifylline—PDE5A—lymph node—salivary gland cancer	0.00398	0.0338	CbGeAlD
Pentoxifylline—ADORA1—lymph node—salivary gland cancer	0.00377	0.0321	CbGeAlD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—CCND1—salivary gland cancer	0.00362	0.00549	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PHGDH—salivary gland cancer	0.00347	0.00526	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00341	0.00518	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ST3GAL4—salivary gland cancer	0.00334	0.00506	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—EP300—salivary gland cancer	0.00333	0.00505	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FGF16—salivary gland cancer	0.00324	0.00491	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—MC3R—salivary gland cancer	0.00317	0.00482	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR4—salivary gland cancer	0.00311	0.00472	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AQP1—salivary gland cancer	0.00303	0.0046	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00279	0.00423	CbGpPWpGaD
Pentoxifylline—PDE4B—lymph node—salivary gland cancer	0.00279	0.0237	CbGeAlD
Pentoxifylline—ADORA2B—GPCR downstream signaling—MC3R—salivary gland cancer	0.00273	0.00415	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO3—salivary gland cancer	0.00258	0.00392	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00253	0.00384	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MC3R—salivary gland cancer	0.00248	0.00376	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00248	0.00376	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NUP62—salivary gland cancer	0.0024	0.00365	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FGFR4—salivary gland cancer	0.00239	0.00363	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—VCAN—salivary gland cancer	0.00238	0.00362	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00237	0.0036	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00234	0.00356	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—MC3R—salivary gland cancer	0.00232	0.00352	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—MC3R—salivary gland cancer	0.0023	0.00348	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—HRAS—salivary gland cancer	0.00228	0.00346	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MC3R—salivary gland cancer	0.00225	0.00342	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MC3R—salivary gland cancer	0.00211	0.0032	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAP2K2—salivary gland cancer	0.00211	0.0032	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MC3R—salivary gland cancer	0.00208	0.00316	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FOXO3—salivary gland cancer	0.00199	0.00301	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00191	0.00289	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WNT5B—salivary gland cancer	0.00186	0.00282	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00183	0.00278	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL17RD—salivary gland cancer	0.0018	0.00273	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00179	0.00272	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00176	0.00268	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—CREBBP—salivary gland cancer	0.00174	0.00264	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WNT5B—salivary gland cancer	0.00169	0.00256	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAML3—salivary gland cancer	0.00164	0.0025	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL17RD—salivary gland cancer	0.00163	0.00248	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MC3R—salivary gland cancer	0.00163	0.00247	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MAP2K2—salivary gland cancer	0.00162	0.00246	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WNT5B—salivary gland cancer	0.00158	0.0024	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WNT5B—salivary gland cancer	0.00156	0.00237	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL17RD—salivary gland cancer	0.00153	0.00232	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL17RD—salivary gland cancer	0.00151	0.00229	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAML3—salivary gland cancer	0.00149	0.00227	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—PTEN—salivary gland cancer	0.00148	0.00224	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MC3R—salivary gland cancer	0.00147	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00141	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—EP300—salivary gland cancer	0.00141	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAML3—salivary gland cancer	0.0014	0.00212	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAML3—salivary gland cancer	0.00138	0.0021	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MC3R—salivary gland cancer	0.00133	0.00202	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00128	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DTX4—salivary gland cancer	0.00128	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MC3R—salivary gland cancer	0.00125	0.00189	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MC3R—salivary gland cancer	0.00123	0.00187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WNT5B—salivary gland cancer	0.00122	0.00185	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.0012	0.00182	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—EP300—salivary gland cancer	0.00119	0.0018	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00119	0.0018	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL17RD—salivary gland cancer	0.00118	0.00179	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DTX4—salivary gland cancer	0.00116	0.00177	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—PTEN—salivary gland cancer	0.00114	0.00173	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.00112	0.0017	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DTX4—salivary gland cancer	0.00109	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—EP300—salivary gland cancer	0.00109	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAML3—salivary gland cancer	0.00108	0.00164	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DTX4—salivary gland cancer	0.00108	0.00163	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGF16—salivary gland cancer	0.00106	0.00161	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—salivary gland cancer	0.00101	0.00153	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000982	0.00149	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.000982	0.00149	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGF16—salivary gland cancer	0.000962	0.00146	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MC3R—salivary gland cancer	0.000962	0.00146	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CREBBP—salivary gland cancer	0.000932	0.00141	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000926	0.00141	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAML2—salivary gland cancer	0.000921	0.0014	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGF16—salivary gland cancer	0.000901	0.00137	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000898	0.00136	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGF16—salivary gland cancer	0.00089	0.00135	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—PIK3CA—salivary gland cancer	0.000878	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PTEN—salivary gland cancer	0.00086	0.0013	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—salivary gland cancer	0.000849	0.00129	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DTX4—salivary gland cancer	0.000841	0.00128	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAML2—salivary gland cancer	0.000836	0.00127	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000815	0.00124	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—HRAS—salivary gland cancer	0.000812	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000789	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JAG1—salivary gland cancer	0.000786	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAML2—salivary gland cancer	0.000783	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGFR4—salivary gland cancer	0.000783	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—salivary gland cancer	0.000778	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAML2—salivary gland cancer	0.000773	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FBXW7—salivary gland cancer	0.00077	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000763	0.00116	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000754	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.00073	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JAG1—salivary gland cancer	0.000714	0.00108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGFR4—salivary gland cancer	0.000711	0.00108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FBXW7—salivary gland cancer	0.000699	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGF16—salivary gland cancer	0.000696	0.00106	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000672	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JAG1—salivary gland cancer	0.000668	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGFR4—salivary gland cancer	0.000666	0.00101	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTEN—salivary gland cancer	0.000666	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JAG1—salivary gland cancer	0.00066	0.001	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGFR4—salivary gland cancer	0.000658	0.000998	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FBXW7—salivary gland cancer	0.000655	0.000993	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FOXO3—salivary gland cancer	0.00065	0.000985	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FBXW7—salivary gland cancer	0.000647	0.000982	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—salivary gland cancer	0.000635	0.000963	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PIK3CA—salivary gland cancer	0.000607	0.00092	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAML2—salivary gland cancer	0.000604	0.000917	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FOXO3—salivary gland cancer	0.00059	0.000895	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000589	0.000894	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—HRAS—salivary gland cancer	0.000561	0.000852	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FOXO3—salivary gland cancer	0.000552	0.000838	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FOXO3—salivary gland cancer	0.000546	0.000828	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAP2K2—salivary gland cancer	0.00053	0.000805	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000517	0.000784	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JAG1—salivary gland cancer	0.000516	0.000783	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR4—salivary gland cancer	0.000514	0.00078	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FBXW7—salivary gland cancer	0.000506	0.000767	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000482	0.000731	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—salivary gland cancer	0.000469	0.000712	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000451	0.000684	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000446	0.000676	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000435	0.000659	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FOXO3—salivary gland cancer	0.000426	0.000647	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000421	0.000639	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000395	0.000599	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000394	0.000598	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000392	0.000594	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00037	0.000561	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH1—salivary gland cancer	0.00037	0.000561	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000365	0.000554	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CREBBP—salivary gland cancer	0.000358	0.000543	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000348	0.000528	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000336	0.00051	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000336	0.00051	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CREBBP—salivary gland cancer	0.000335	0.000508	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CREBBP—salivary gland cancer	0.000331	0.000502	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000319	0.000485	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000315	0.000477	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000311	0.000472	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—salivary gland cancer	0.000311	0.000472	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000307	0.000466	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000305	0.000463	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—salivary gland cancer	0.000292	0.000442	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000286	0.000433	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000285	0.000433	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000282	0.000428	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—salivary gland cancer	0.000282	0.000428	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—salivary gland cancer	0.000281	0.000427	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000279	0.000424	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—salivary gland cancer	0.000268	0.000407	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—salivary gland cancer	0.000265	0.000402	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—salivary gland cancer	0.000264	0.000401	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—salivary gland cancer	0.000261	0.000396	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CREBBP—salivary gland cancer	0.000259	0.000392	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—salivary gland cancer	0.000256	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—salivary gland cancer	0.000248	0.000376	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—salivary gland cancer	0.000245	0.000372	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—salivary gland cancer	0.000244	0.00037	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000243	0.000369	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—salivary gland cancer	0.000239	0.000363	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—salivary gland cancer	0.000236	0.000359	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—salivary gland cancer	0.000228	0.000346	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—salivary gland cancer	0.000225	0.000342	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000221	0.000336	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000221	0.000335	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.00022	0.000333	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—salivary gland cancer	0.000204	0.00031	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000199	0.000301	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000193	0.000292	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—salivary gland cancer	0.000192	0.000291	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—salivary gland cancer	0.000191	0.00029	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—salivary gland cancer	0.000185	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—salivary gland cancer	0.000184	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—salivary gland cancer	0.00018	0.000273	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—salivary gland cancer	0.000176	0.000267	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—salivary gland cancer	0.000174	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000169	0.000256	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000167	0.000253	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—salivary gland cancer	0.000167	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—salivary gland cancer	0.000163	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—salivary gland cancer	0.000161	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—salivary gland cancer	0.000156	0.000237	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—salivary gland cancer	0.000154	0.000234	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000138	0.000209	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000131	0.000199	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—salivary gland cancer	0.00013	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—salivary gland cancer	0.000126	0.000191	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—salivary gland cancer	0.000121	0.000183	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.71e-05	0.000147	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CREBBP—salivary gland cancer	8.59e-05	0.00013	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—salivary gland cancer	6.13e-05	9.3e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—salivary gland cancer	5.85e-05	8.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	4.33e-05	6.56e-05	CbGpPWpGaD
